Latest news on Alzheimer's

BBRC
Congresses and events
Research studies
Research and scientific results
External projects
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
Over the course of the five days, more than 20 world specialists will share their experiences and debate with the attendees about the main lines of research and current research techniques in the field of biomarkers for neurodegenerative diseases.
13 Mar | 2023

The BBRC hosts the sixth edition of the Workshop on biomarkers for neurodegenerative diseases

The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.

Biomarkers
The distinction has been granted by a jury representing the Catalan Association of Telecommunications Engineering and Digital Technologies and the Official College of Computer Engineering of Catalonia.
10 Mar | 2023

Arcadi Navarro receives the Award of Honor of the Telecommunications and IT Night

The Telecommunications Night Award of Honor distinguishes a public or private personality with a wide and distinguished professional career related to Electronics, Information and Communication Technologies or Audiovisual in the technical, academic, business or institutional field within the State.

The proposal is detailed in an article published in the scientific journal The Lancet Regional Health - Europe, and includes the creation of second-generation memory clinics, called 'Brain Health Services'.
22 Feb | 2023

28 European institutions establish new guidelines to prevent Alzheimer's

An international initiative with the participation of the BBRC has published a protocol for the creation of Brain Health Services, intended for the attention of people without cognitive impairment who wish to preserve or improve their memory.

Dementia
From left to right; Alba Cañas, Patricia Genius, Iva Knezevic
11 Feb | 2023

We join the International Day of Women and Girls in Science

Three BBRC professionals give us their vision of women in the scientific field

The PMRP is the most important private aid program in Spain specifically intended for research on Alzheimer's or other age-related neurodegenerative diseases.
02 Feb | 2023

Success of the first call for Pasqual Maragall Researchers Program scholarships with more than 60 applications received

Requests have been received from research centers in eight autonomous communities in Spain. Among the collaborators, a total of 17 researchers come from international centers.

The research has the voluntary participation of two hundred people without cognitive impairment from the ALFA+ Study, with the support of the "la Caixa" Foundation
18 Jan | 2023

BBRC's AlfaSleep project publishes an observational study protocol on sleep quality and its relationship with Alzheimer's disease

The research has the voluntary participation of two hundred people without cognitive impairment from the ALFA+ Study, with the support of the "la Caixa" Foundation

The investigations have been led by the Barcelonaβeta Brain Research Center (BBRC) and have included participants without cognitive alterations from the ALFA Study, with the support of the ”la Caixa” Foundation
19 Dec | 2022

We found that a genetic predisposition to longer telomeres could have a protective effect against Alzheimer's

The investigations have been led by the Barcelonaβeta Brain Research Center (BBRC) and have included participants without cognitive alterations from the ALFA Study, with the support of the ”la Caixa” Foundation

Dr. Argimon will lead the development and management of the research infrastructures, studies and cohorts of the BBRC.
05 Dec | 2022

Dr. Josep Maria Argimon, appointed Director of the Scientific Infrastructure of the Barcelonaβeta Brain Research Center

The Research Center of the Pasqual Maragall Foundation incorporates Dr. Argimon to lead the development and management of its research infrastructures, studies and cohorts.

The results, published in The New England Journal of Medicine, confirm that lecanemab slows cognitive decline by 27% in patients in the early stages of Alzheimer's disease.
30 Nov | 2022

A new research drug against Alzheimer's confirms its positive results during CTAD

The results, published in The New England Journal of Medicine, confirm that lecanemab slows cognitive decline by 27% in patients in the early stages of Alzheimer's disease.